Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
A high-fat diet does more than overload the liver with fat. New research from MIT shows that prolonged exposure to fatty foods can push liver cells into a survival mode that quietly raises the risk of ...
New MIT research uncovers how high-fat diets push liver cells into a primitive state, elevating cancer risk. Learn how fatty foods impact liver function and cancer development.
SCOUT-HCM demonstrated the superiority of Camzyos on the primary endpoint and multiple secondary endpointsThe overall safety results in this study were consistent with the established safety profile ...
Rallybio Corporation (RLYB) announced an update on their ongoing clinical study.
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...
4don MSN
Immune stress during pregnancy changes how fetal brain cells communicate, mouse study reveals
Research led by the SickKids Research Institute in Toronto and the University of Pennsylvania, has found that immune-related ...
Hosted on MSN
The full human evolution timeline explained
Human evolution is not a straight line but a complex branching tree shared with other great apes. This overview explains the distinction between hominids and hominins and traces the evolutionary ...
Fossils from Nesher Ramla in Israel show a combination of archaic and modern traits that do not match known human species. Researchers suggest this population represents a previously unrecognized ...
Scientists recently discovered what may be the earliest evidence of deliberate fire-making by humans — and it’s far older than scholars previously believed. The study, which was published in the ...
News-Medical.Net on MSN
Understanding the impact of pregnancy stressors on neuroimmune landscape of the fetal brain
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results